438 results on '"Bruserud Ø"'
Search Results
2. Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia
3. Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia
4. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels
5. Animal models of acute myelogenous leukaemia – development, application and future perspectives
6. In sepsis, 88% of bacteraemia patients are discriminated by unsupervised hierarchical cluster analysis of 5 inflammatory mediators
7. Antiproliferative effects of a non-β-oxidizable fatty acid, tetradecylthioacetic acid, in native human acute myelogenous leukemia blast cultures
8. Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases
9. The surface molecule signature of primary human acute myeloid leukemia (AML) cells is highly associated with NPM1 mutation status
10. Acute myelogenous leukemia blasts as accessory cells during T lymphocyte activation: possible implications for future therapeutic strategies
11. Serum levels of the IL-33 decoy receptor soluble ST2; a possible prognostic marker in clear-cell renal cell carcinoma
12. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft
13. Acute myelogenous leukemia in a patient with Li–Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report
14. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of normal polyclonal T cells and T lymphocyte clones derived early after allogeneic bone marrow transplantation
15. Measurements of in vitro platelet quality parameters in photochemical treated and gamma-irradiated single-donor platelet concentrates during storage: 40
16. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2 × 106 CD34+ cells/kg
17. Serum levels of angioregulatory mediators in healthy individuals depend on age and physical activity: Studies of angiogenin, basic fibroblast growth factor, leptin and endostatin
18. Characterization of Ribosomal P Autoantibodies in Relation to Cell Destruction and Autoimmune Disease
19. Editorial Acknowledgment
20. In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts
21. T-Lymphocyte Functions in Acute Leukaemia Patients with Severe Chemotherapy-Induced Cytopenia: Characterization of Clonogenic T-cell Proliferation
22. Expression of Fcε-receptors by human acute myelogenous leukemia (AML) blasts: studies of high- and low- (CD23) affinity receptor expression and the effects of IgE-mediated receptor ligation on functional AML blast characteristics
23. Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia
24. Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells
25. A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation
26. The Role of Human Class II Molecules in Activation of T4 Lymphocytes
27. Serum levels of soluble ICAM-1 in acute leukemia patients with chemotherapy-induced neutropenia
28. A prospective observational study on effects of fever on red cell transfusion outcome
29. Serum thrombopoietin levels in acute leukemia patients with chemotherapy-induced cytopenia – inverse correlation between serum levels and platelet counts
30. Response to K Shinjo et al
31. Comment from Ø Bruseard
32. HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with Type 1 (insulin-dependent) diabetes and healthy subjects
33. Malignancy: Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34+ Cells in Multiple Myeloma Patients
34. Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients
35. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia
36. Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis
37. Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia
38. The surface molecule signature of primary human acute myeloid leukemia (AML) cells is highly associated with NPM1 mutation status
39. Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia
40. Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia
41. Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia
42. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels
43. The Role of the CD8-Positive Subset of T Cells in Proliferative Responses to Soluble Antigens
44. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2×106 CD34+ cells/kg
45. Circadian variations do not have a major impact on serum levels of soluble (s) L-selectin (CD63L), s-intercellular adhesion molecule 1 (sICAM-1/CD54) and thrombopoietin in healthy individuals
46. Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia
47. Insulin‐Like Growth Factor‐1 (IGF‐1) has a Costimulatory Effect on Proliferation of Committed Progenitors Derived from Human Umbilical Cord CD34 + Cells
48. Effects of acute myelogenous leukemia blasts on platelet release of soluble P-selectin and platelet-derived growth factor
49. Effects of Hematopoietic Growth Factors on Interleukin 6 Secretion by Blast Cells Derived from Acute Myelogenous Leukemia Patients
50. Secretion of IL‐2, IL‐3, IL‐4, IL‐6 and GM‐CSF by CD4+ and CD8+ TCRαβ+ T‐Cell Clones derived early after Allogeneic Bone Marrow Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.